Literature DB >> 3409550

Chronology of halothane-induced antigen expression in halothane-exposed rabbits.

T P Roth1, A K Hubbard, A J Gandolfi, B R Brown.   

Abstract

Multiple halothane exposures in rabbits generate modified liver proteins or antigens that appear to incorporate the metabolic intermediate of halothane, trifluoroacetyl halide (TFA), as identified by specific anti-TFA antibody. These halothane-induced antigens are most prevalent throughout the second to fourth days following a single halothane exposure and are in highest concentration after the second and third exposure. In addition, five consecutive halothane exposures at 2-week intervals caused the sustained expression of these halothane-induced antigens throughout the first 4 days following the last exposure. By the seventh day, however, antigen expression began to decline. Although there is great heterogeneity in the molecular weights of the halothane-induced antigens, the predominant proteins appear to be 85k, 58k, 53k, 37k and 24k. These liver proteins could reflect self proteins altered by trifluoroacetylation by halothane metabolites and may be potential immunogens in the initiation of a halothane-induced immune response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409550      PMCID: PMC1541549     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Specific serological markers in the diagnosis of fulminant hepatic failure associated with halothane anaesthesia.

Authors:  J Neuberger; A E Gimson; M Davis; R Williams
Journal:  Br J Anaesth       Date:  1983-01       Impact factor: 9.166

3.  Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro.

Authors:  H Uehleke; K H Hellmer; S Tabarelli-Poplawski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Halothans hepatitis: allergy or idiosyncrasy?

Authors:  J L Dienstag
Journal:  N Engl J Med       Date:  1980-07-10       Impact factor: 91.245

5.  Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes.

Authors:  H Satoh; Y Fukuda; D K Anderson; V J Ferrans; J R Gillette; L R Pohl
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

6.  Characterization of a halothane-induced humoral immune response in rabbits.

Authors:  A H Callis; S D Brooks; T P Roth; A J Gandolfi; B R Brown
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

7.  Bioactivation and covalent binding of halothane in vitro: studies with [3H]- and [14C]halothane.

Authors:  A J Gandolfi; R D White; I G Sipes; L R Pohl
Journal:  J Pharmacol Exp Ther       Date:  1980-09       Impact factor: 4.030

8.  Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis.

Authors:  D Vergani; G Mieli-Vergani; A Alberti; J Neuberger; A L Eddleston; M Davis; R Williams
Journal:  N Engl J Med       Date:  1980-07-10       Impact factor: 91.245

  8 in total
  2 in total

1.  Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage.

Authors:  Y Sakaguchi; S Inaba; K Irita; H Sakai; H Nawata; S Takahashi
Journal:  Can J Anaesth       Date:  1994-05       Impact factor: 5.063

2.  Localization of halothane-induced antigen in situ by specific anti-halothane metabolite antibodies.

Authors:  A K Hubbard; T P Roth; S Schuman; A J Gandolfi
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.